Dow Pares Some Losses But Remains in Red on Tech Wreck By Investing.com

Dow Eases From Highs on Rising Infections, but Jobs Surge


© Reuters.

By Yasin Ebrahim

Investing.com – The Dow pared some losses Thursday, but remained in the red as technology stocks slumped and weakness in the labor market exacerbated concerns about the pace of the recovery at a time when further stimulus is unlikely in the immediate future.

The fell 0.12%, or 35 points. The was down 0.30%, while the slumped 0.75%.

The Fab 5 led the broader tech stocks lower as investors appear to be taking profit on big tech following the recent run higher, with analysts warning of a choppy month ahead.

“[O]ur optics still suggest a choppy bottoming process in the October-November timeframe with a floor around/above 3050-3150 SPX,” Technical Strategist Dan Wantrobski said.

Apple (NASDAQ:), Amazon.com (NASDAQ:), Facebook (NASDAQ:), Google-parent Alphabet (NASDAQ:) and Microsoft  (NASDAQ:) traded in the red.

Investor sentiment was also hurt by data suggesting the resilience seen in the labor market could start to give away without further stimulus to support the broader economy.

The Labor Department said 898,000 Americans filed for unemployment insurance, up 53,000 from the prior week’s 845,000. That was above economists’ estimates for 820,000 claims and the highest since Aug. 22.

“The bottom line here is that the state of the labor market is contingent on the virus picture, so we can’t rule out further increases, and at this point we’d regard a zero print for October payrolls as a decent result; a clear decline is entirely possible,” Pantheon Macroeconomics said.

A day after conceding that stimulus was unlikely to be rolled out before the Nov. 3 election, Treasury Secretary Steven Mnuchin said he would continue talks with House Speaker Nancy Pelosi on Thursday to resolve differences, particularly on funding for a national testing plan, which remains a sticking point.  

Healthcare stocks were also among the biggest losers on the day, led by 20% slump in Vertex Pharmaceuticals (NASDAQ:) after it stopped testing on a protein deficient treatment amid safety concerns.

Walgreens Boots Alliance (NASDAQ:) rose 3% after reporting better-than-expected quarterly results, underpinned by higher U.S. sales.

Elsewhere on the earnings front, United Airlines Holdings Inc (NASDAQ:) slumped more than 4% after its second-quarter results,  released late-Wednesday, fell short of Wall Street estimates as the pandemic continues to weigh on air travel.

Energy, meanwhile, was pressured by a fall in oil prices as concerns about demand in the wake of a resurgence in the spread of Covid-19 offset data showing a larger-than-expected draw in weekly inventories.  

In other news, cloud computing company Fastly (NYSE:) plunged 27% after trimming its third-quarter guidance, citing an uncertain geopolitical backdrop and lower-than-expected demand.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Source link

Investing.com


Leave a Reply

Your email address will not be published. Required fields are marked *


About us

InvestLab is a financial services technology company focused on the global trading market. Founded in 2010 in Hong Kong, the company develops trading, market data, and social research products that enable individual investors and small to mid-size brokers to access global markets. We provide brokers and financial institutions cross border capabilities for retail investors into 43 markets globally.


CONTACT US

CALL US ANYTIME